Explore some of the main issues in the treatment of advanced RCC through two cases.
This activity is intended for oncologists, nephrologists, urologists, and other healthcare professionals who treat patients with advanced RCC.
The goal of this activity is to examine the options for second-line treatment of mRCC as well as strategies for working with the patient.
Approximate Time to Complete: 1 hour
Course Available Beginning: Sep. 21, 2016
Developed through a partnership between SITC and Medscape.
Upon completion of this activity, participants will be able to:
- Assess recent clinical evidence on individual factors and disease histology that may influence individualized treatment choices
- Apply best practices for patient communication and patient-centered management to identify and respond to patient information needs and elicit patient preferences when selecting therapies for patients with mRCC